An FDA committee said new data allay concerns about the risk of stroke and cardiovascular events previously associated with tiotropium (Spiriva), drugmaker Boehringer Ingelheim said.
FDA Panel Finds Tiotropium Safe for COPD PatientsCourtesy MedPage Today Allergy & Immunology Fri, 11/20/2009 - 11:42
An FDA committee said new data allay concerns about the risk of stroke and cardiovascular events previously associated with tiotropium (Spiriva), drugmaker Boehringer Ingelheim said. Popular products More related itemsFDA panel backs inhalable drug for lung infection
FDA Panel Rejects Cell Culture Flu Vaccine, Wants...
FDA Panel Considers New Cell-Based Flu Vaccine
Nasaline Nasal Irrigator
Wahl 9877-500 "The Goatee" Advanced Dual Blade,...
|
Popular by tags WeekMonth |
Post new comment